Results 161 to 170 of about 79,996 (276)

Acute Finger Ischemia Evaluated With Point‐Of‐Care‐Ultrasound and Diagnosed With Concurrent Polycythemia Vera, Antiphospholipid Syndrome, and Tobacco Use

Clinical Case Reports, Volume 14, Issue 6, June 2026.
We present a case of digital ischemia investigated and localized using point‐of‐care ultrasound (POCUS), in a patient that was subsrquently diagnosed with antiphospholipid syndrome and polycythemia vera concurrently, in the setting of active tobacco use. ABSTRACT In patients with undifferentiated extremity ischemia, point‐of‐care ultrasound (POCUS) can
Tristan Burgess, Michael C. Larkins, Titus Chu   +2 more
wiley   +1 more source

Effect of Hyperthermia on Prothrombin Time (PT), International Normalized Ratio (INR), and Activated Partial Thromboplastin Time (APTT). [PDF]

Cureus
Devi J, Kakkar N, Sharma A.
europepmc   +1 more source

Investigation of sensitivity for coagulation factor deficiency in APTT and PT : how to perform it? [PDF]

, 2016
Devreese, Katrien, Dumoulin, Els, Fiers, Lisse   +2 more
core   +1 more source

Toxicological Evaluation of the Roots of Ficus pandurata Hance var. angustifolia Cheng

Food Science &Nutrition, Volume 14, Issue 6, June 2026.
Toxicological evaluation of the roots of Ficus pandurata Hance var. angustifolia Cheng for safe utilization. Two‐year‐old RFPH roots were prepared as an aqueous extract powder, with 1 g equivalent to 30 g of raw material. Acute oral toxicity, genotoxicity, teratogenicity, and 90‐day repeated‐dose oral toxicity tests were performed in SD rats and ICR ...
Yamin Chen, Zhijing Fu, Fangfang Ma, Siyuan Wang, Junjie Pan, Huaxing Luo, Zhen Liu, Jianguo Chen, Jingjin Hu, Yangjunna Zhang, Kejun Cheng, Ye Jin, Xuefeng Qu   +12 more
wiley   +1 more source

Association between activated partial thromboplastin time and septic shock in pregnant women: a retrospective cohort study. [PDF]

Front Med (Lausanne)
Zheng S, Chen D, Gao Y.
europepmc   +1 more source

Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time-based clotting time test results in patients treated with emicizumab. [PDF]

Res Pract Thromb Haemost, 2023
Novembrino C, Boscolo-Anzoletti M, Galbiati E, Shinohara S, Peyvandi F.   +4 more
europepmc   +1 more source

Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Antithrombotic-Treated Cardiac Patients: A Cross-Sectional Study from Sana'a City, Yemen. [PDF]

Vasc Health Risk Manag
Amer AH, Al-Adhroey AH, Al-Shammakh AA.
europepmc   +1 more source

Multi‐Layered Genomic and Clinical Analysis Identifies Novel Variants, Co‐Occurring Single Nucleotide Polymorphism Pairs, and Clinical Determinants of Host‐Pathogen Interaction in COVID‐19 Severity

Journal of Medical Virology, Volume 98, Issue 6, June 2026.
ABSTRACT Host genetic factors may contribute to COVID‐19 severity. To identify genetic variants influencing COVID‐19 severity progression, whole‐exome sequencing was performed, followed by an exome‐wide association study on 191 hospitalized patients categorized into three severity groups.
Doris Repušić, Marina Korolija, Ana Livun, Tomo Svaguša, Robert Belužić, Vjekoslav Tomaić, Rosa Karlić, Kristian Vlahoviček   +7 more
wiley   +1 more source

Normalization of activated partial thromboplastin time and diluted Russell's viper venom time ratios can be safely omitted in the assessment of lupus anticoagulant. [PDF]

Res Pract Thromb Haemost
Kimiaei A, Antovic J, Gran C.
europepmc   +1 more source

Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study. [PDF]

Diagnostics (Basel), 2023
Wong WH, Tan CW, Abdul Khalid NB, Dalimoenthe NZ, Yip C, Tantanate C, Lim RD, Kim JH, Ng HJ.   +8 more
europepmc   +1 more source